(19)
(11) EP 1 244 356 A1

(12)

(43) Date of publication:
02.10.2002 Bulletin 2002/40

(21) Application number: 00988189.7

(22) Date of filing: 19.12.2000
(51) International Patent Classification (IPC)7: A01N 43/04, A61K 31/70, C07H 19/00, C07H 19/04, C07H 19/044
(86) International application number:
PCT/US0034/605
(87) International publication number:
WO 0104/5509 (28.06.2001 Gazette 2001/26)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.12.1999 US 172097 P
29.12.1999 US 173446 P
06.01.2000 US 175111 P
20.03.2000 US 190758 P
22.08.2000 US 226947 P
22.08.2000 US 226875 P
19.09.2000 US 233821 P
19.09.2000 US 233823 P
19.09.2000 US 233548 P
19.09.2000 US 233822 P
26.09.2000 US 235465 P

(71) Applicant: ICN Pharmaceuticals, Inc.
Costa Mesa, CA 92626 (US)

(72) Inventors:
  • LAU, Johnson
    Costa Mesa, CA 92626 (US)
  • HONG, Zhi
    Costa Mesa, CA 92626 (US)
  • TAM, Robert
    Costa Mesa, CA 92626 (US)
  • RAMASAMY, Kanda
    Costa Mesa, CA 92626 (US)
  • LIN, Chin-chung
    Costa Mesa, CA 92626 (US)
  • ZEYTIN, Füsûn
    Costa Mesa, CA 92626 (US)
  • RAKIC, Ljubisa
    Costa Mesa, CA 92626 (US)

(74) Representative: Viering, Jentschura & Partner 
Steinsdorfstrasse 6
80538 München
80538 München (DE)

   


(54) COMPOSITIONS AND METHODS FOR L-NUCLEOSIDES, L-NUCLEOTIDES, AND THEIR ANALOGS